SynQor Prevails on Post-Judgment Motions; New IBA Case Opened

SynQor Prevails on Post-Judgment Motions; New IBA Case Opened

BOXBOROUGH, MA — (Marketwire) — 10/05/11 — SynQor, Inc. today announced that late last week, in the matter SynQor, Inc. v. Artesyn Technologies, Inc., et al., Civil Action No. 2:07-CV-497-TJW-CE, the U.S. District Court for the Eastern District of Texas denied all of the defendants- post-trial challenges to the jury verdict and the Court-s prior rulings.In ruling for SynQor the Court stated:
The Court has carefully considered the parties- submissions, the record, and the applicable law. As

SynQor Awarded New IBA Patent; New Patent Added to Lawsuit Against Vicor

SynQor Awarded New IBA Patent; New Patent Added to Lawsuit Against Vicor

BOXBOROUGH, MA — (Marketwire) — 10/04/11 — today the issuance of U.S. Patent No. 8,023,290 by the Patent and Trademark Office effective September 20, 2011. The -290 patent is the latest in a series of patents issued to SynQor relating to . Promptly following the issuance of the -290 patent the U.S. District Court for the Eastern District of Texas granted SynQor-s request to add this patent to the pending patent infringement suit SynQor has against Vicor Corporation and Cisco Systems.Dr. M

ATLAS Biolabs to take part in NGSgoesHPC, a publicly funded research program to improve the computational analysis of next-generation sequencing data

Berlin, September 27, 2011 – ATLAS Biolabs announces its participation in a joint bioinformatics project called NGSgoesHPC funded by the German Federal Ministry of Education and Research (BMBF). The project-s aim is to develop new applications promoting the efficient use of modern high-performance computers (HPC) in the analysis and interpretation of DNA sequencing data. By taking part in NGSgoesHPC, ATLAS Biolabs seeks not only to advance an important aspect of computational biology, it is also